To catalogue

Pharm-Rx Hyoscyamine Sulfate

CAS Number
6835-16-1
Chemical Name
Hyoscyamine Sulfate
Molecular Formula
(C₁₇H₂₃NO₃)₂ · H₂SO₄ · 2H₂O

Pharm-Rx Hyoscyamine Sulfate is categorized under active pharmaceutical ingredients (APIs) within pharmaceuticals and nutraceuticals technologies, comprising hyoscyamine sulfate, Pharm-Rx Hyoscyamine Sulfate is an essential component in pharmaceutical actives and precursors.

Properties

Physical Form
Powder

Product families

Applications

Healthcare & Pharma — Drug Delivery & Care Solutions
  • Other Drug & Care Solutions

Product Families

Pharmaceuticals & Nutraceuticals — Pharmaceutical Actives & Precursors
  • Active Pharmaceutical Ingredients (APIs)

Other characteristics

Chemical Inventories

AICS (Australia), EINECS (EU), ENCS (Japan), NDSL (Canada), NZIoC (New Zealand), PICCS (Phillipines), TSCA (USA); AICS (Australia); EINECS (EU); ENCS (Japan); NDSL (Canada); NZIoC (New Zealand); PICCS (Phillipines); TSCA (USA)

Certifications & Compliance
California Proposition 65, FDA 29 CFR 1910.1200
Markets
Healthcare & Pharma
Definition

Hyoscyamine Sulfate contains not less than 98.0% and not more than 102.0% of hyoscyamine sulfate [(C₁₇H₂₃NO₃)₂ · H₂SO₄], calculated on the anhydrous basis.

Soluble In
  • Alcohol Soluble
  • Water Soluble
Technology
Pharmaceuticals & Nutraceuticals
FDA Disclaimer

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Storage Information
Preserve in tight, light-resistant containers.
USP Reference Standards

USP Hyoscyamine Sulfate RS USP Hyoscyamine Related Compound A RS Norhyoscyamine sulfate; (1R,3r,5S)-8-Azabicyclo[3.2.1]oct-3-yl(2S)-3-hydroxy- 2-phenylpropanoate sulfate (2:1). C32H44N2O10S 648.77

Certifications and Compliance
  • California Proposition 65
  • FDA 29 CFR 1910.1200

Technical data

Table 1 of 1

1 row
CharacteristicValue
Molecular Weight712.85

The Omnichem website uses cookies. By continuing to use the site, you consent to their use in accordance with our Privacy Policy and to the collection of analytics.